GL1X · GenesisL1 explorer

MolNFT v1 · #149348 · protein

Crystal structure of ERK2 in complex with an adenosine derivative

6FXV · Mitogen-activated protein kinase 1: “Crystal structure of ERK2 in complex with an adenosine derivative”. X-ray diffraction, 2 ligands (E9W, SO4), 4 pockets (best druggability 0.65). MolNFT v1 #149348 on GenesisL1: 3D structure…

PDB
6FXV
Type
protein
Length
337 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 1
EC
2.7.11.24
UniProt
P63086
Ligands
E9W, SO4
Pockets
4 · best druggability 0.65

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase 1 (EC 2.7.11.24)protein33740% helix, 15% strandP63086

Ligands and binding sites

  • E9W · azanylidene-[[(2~{R},3~{S},4~{R},5~{R})-5-[6-azanyl-8-[2-oxidanylidene-2-(prop-2-ynylamino)ethyl]sulfanyl-purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methylimino]azanium · ligand · chains A
  • SO4 · Sulfate ion · ion · chains A
  • DMS · Dimethyl sulfoxide · additive · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13230.650.8031E9W
21300.540.8226empty
3810.350.7515empty
4720.330.7519empty

Modifications

Observed in the structure: 2 modified (artifact).

Compared structures

  • 6FXV · Crystal structure of ERK2 in complex with an adenosine derivative · the same entry in another collection · chain A against A, TM-score 1.00
  • P63086 · AlphaFold monomer V2.0 prediction for mitogen-activated protein kinase 1 (P63086) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.